期刊
AMERICAN JOURNAL OF KIDNEY DISEASES
卷 48, 期 4, 页码 519-536出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.ajkd.2006.07.006
关键词
anemia; renal transplant; renal function; immunosuppression; erythropoiesis-stimulating agents
资金
- Medical Research Council [G0500429] Funding Source: Medline
- Medical Research Council [G0500429] Funding Source: researchfish
- MRC [G0500429] Funding Source: UKRI
Anemia in the setting of chronic kidney disease is a well-recognized phenomenon that is associated with decreasing renal function and deficiency of or resistance to erythropoietin. However, anemia in the post-renal transplantation setting has received comparatively less attention in the literature. In this review, we aim critically to appraise the available literature regarding posttransplantation anemia, concentrating in particular on the prevalence of posttransplantation anemia, its etiopathogenesis, potential effects on morbidity and mortality, and the rationale for intervention and treatment. Despite deficiencies in the literature, we conclude that posttransplantation anemia is a common phenomenon that can occur either early or late posttransplantation, and its causation is usually multifactorial and includes contributions notably from poor or decreasing renal function, immunosuppression, and iron deficiency. Conversely, there is a shortage of well-conducted prospective studies looking at the morbidity attributable to posttransplantation anemia and a lack of trial evidence to determine whether intervention improves patient morbidity and outcome.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据